A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
West German Study Group
University of Eastern Finland
Institut du Cancer de Montpellier - Val d'Aurelle
AstraZeneca
Yale University
The University of Texas Health Science Center at San Antonio
Assistance Publique - Hôpitaux de Paris
Institute of Hematology & Blood Diseases Hospital, China
Sun Yat-sen University
AtlasMedx, Incorporated
Stanford University
AC Camargo Cancer Center
Kaohsiung Medical University Chung-Ho Memorial Hospital
Shanghai Zhongshan Hospital